Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4

Nobuhiko Kayagaki, Michael T. Wong, Irma B. Stowe, Sree R. Ramani(PDL BioPharma (United States)), Lino C. Gonzalez(PDL BioPharma (United States)), Sachiko Akashi‐Takamura(Innate Pharma (France)), Kensuke Miyake(Innate Pharma (France)), Juan Zhang, Wyne P. Lee, Artur Muszyński(University of Georgia), Lennart S. Forsberg(University of Georgia), Russell W. Carlson(University of Georgia), Vishva M. Dixit
Science
July 26, 2013
Cited by 1,533

Abstract

Gram-negative bacteria including Escherichia coli, Citrobacter rodentium, Salmonella typhimurium, and Shigella flexneri are sensed in an ill-defined manner by an intracellular inflammasome complex that activates caspase-11. We show that macrophages loaded with synthetic lipid A, E. coli lipopolysaccharide (LPS), or S. typhimurium LPS activate caspase-11 independently of the LPS receptor Toll-like receptor 4 (TLR4). Consistent with lipid A triggering the noncanonical inflammasome, LPS containing a divergent lipid A structure antagonized caspase-11 activation in response to E. coli LPS or Gram-negative bacteria. Moreover, LPS-mutant E. coli failed to activate caspase-11. Tlr4(-/-) mice primed with TLR3 agonist polyinosinic:polycytidylic acid [poly(I:C)] to induce pro-caspase-11 expression were as susceptible as wild-type mice were to sepsis induced by E. coli LPS. These data unveil a TLR4-independent mechanism for innate immune recognition of LPS.


Related Papers

No related papers found

Powered by citation graph analysis